摘要
为探讨肝癌介入治疗后影响甲胎蛋白（ＡＦＰ）下降的有关因素，本文对４Ｏ例原发性肝癌经肝动脉化疗栓塞术（ＴＡＣＥ）后ＡＦＰ浓度变化进行分析，结果发现多结节型肝癌以及ＴＡＣＥ后肿块不变或增大者，出现肝内及肝外转移者、血清铁蛋白增高者、病情加重者，其ＡＲＰ值不易下降，上述指标在ＴＡＣＥ后ＡＦＰ仍≥４００ｎｇ／ｍＬ组与ＡＴＣＥ后ＡＦＰ≤２５０ｎｇ／ｍＬ组之间存在显著差异性（Ｐ＜０．０５），提示ＴＡＣＥ后检测ＡＦＰ助于肝癌临床过程的观察随访和治疗评价。
s: For inquiring into reflection factors of α-fetoprotein(AFP) reduction after treatment by transcantheter arterial chemoembolization(TACE),40 cases with primary hepatocellular cancer (HCC) were inverstigated. The results show that the level of AFP was difficult to reduce under following factors including node type cancer,tumor no repression, tumor metastasis,Serum ironprotein increase and disease deteriorated. After TACE the factors as above appear a significance difference between AFP level above 400ng/ml and less 250ng/ml(P<(0.05).The inspecting AFP level after TACE has help to know treating effect and determine prognosis.
出处
《河北医学》
CAS
1995年第6期371-373,共3页
Hebei Medicine
关键词
肝癌
甲胎蛋白
化疗栓塞
Liver cancer
α-fetoprotein
Transcantheter arterial Chemoembolizotion
